Ivermectin Research Overview
Ivrea Cream 1% is a topical ivermectin formulation manufactured by Ajanta Pharma for research applications. This FDA-approved antiparasitic agent belongs to the avermectin class of compounds, originally derived from Streptomyces avermitilis. Ivermectin demonstrates broad-spectrum antiparasitic activity through selective binding to glutamate-gated chloride channels in invertebrate nerve and muscle cells. Research laboratories at Stroid UK Shop investigate this compound’s mechanisms across parasitological and dermatological studies. The 1% topical concentration provides standardised dosing for laboratory protocols examining antiparasitic pathways and inflammatory response modulation in experimental models.
Laboratory Research Applications
Research teams examine ivermectin’s antiparasitic mechanisms through various experimental protocols. The compound demonstrates efficacy against ectoparasites including Demodex folliculorum and Sarcoptes scabiei in laboratory models. Investigations focus on its interaction with gamma-aminobutyric acid (GABA) and glutamate-gated chloride channels, causing paralysis and death in target parasites. Additionally, researchers study ivermectin’s anti-inflammatory properties through nuclear factor-kappa B (NF-κB) pathway inhibition. Laboratory studies examine its effects on cytokine production and immune cell migration patterns. Scientists utilising compounds from our antiviral drugs collection investigate comparative antiparasitic mechanisms alongside traditional pharmaceutical approaches.
Chemical Specifications
| Parameter | Specification |
|---|---|
| Active ingredient | Ivermectin 1% |
| Manufacturer | Ajanta Pharma |
| Formulation | Topical cream |
| CAS Number | 70288-86-7 |
| Molecular Formula | C₄₈H₇₄O₁₄ |
| Molecular Weight | 875.09 g/mol |
| Storage | Room temperature, dry conditions |
Researchers comparing antiparasitic mechanisms often reference studies involving compounds from our SARMs category and peptides collection to understand tissue-selective therapeutic approaches across different research applications.
Research Compliance Statement
Ivrea Cream 1% is supplied exclusively for in-vitro laboratory research and educational purposes. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must comply with institutional guidelines and local regulations when handling pharmaceutical research materials. All investigations should follow established laboratory safety protocols and proper waste disposal procedures for pharmaceutical compounds.
